Metronomic Chemotherapy Inhibits Tumor Growth and Metastases Development in mice

[Hopeful]

Abstract:

http://www.abstracts2view.com/sabcs10/view.php?nu=SABCS10L_735

Poster:

http://www.abstracts2view.com/sabcs10/viewp.php?nu=P2-16-11

Hopeful

[Rich66]

results clearly show that metronomic chemotherapy with a combination of cyclophosphamide and doxorubicin as an intervention strategy is able to inhibit significantly tumor growth and metastasis development in the M-406 mammary adenocarcinoma tumor-model, while being devoid of toxicity. To our knowledge, this is the first time that a metronomic schedule combining cyclophosphamide and doxorubicin is employed for the treatment of a mammary adenocarcinoma. The characteristics and the effect of the therapeutic schedule herein utilized suggest its implementation at the clinical setting in the near future.
....................................